What is he best known for?
The fields of study he is best known for:
Nanotechnology, Deoxyribozyme, Nanoparticle, Aptamer and Biosensor are his primary areas of study.
The concepts of his Nanotechnology study are interwoven with issues in Molecule, Metal and DNA.
His research integrates issues of RNA and Stereochemistry in his study of DNA.
Yi Lu has researched Deoxyribozyme in several fields, including Combinatorial chemistry, Metal ions in aqueous solution, Substrate and Fluorophore.
His Combinatorial chemistry study integrates concerns from other disciplines, such as Metalloprotein, Biochemistry and Allosteric regulation.
His Aptamer study also includes fields such as
- Analyte that connect with fields like Nucleic acid,
- Biophysics that intertwine with fields like Ribozyme,
- Liposome most often made with reference to Drug delivery.
His most cited work include:
- Functional Nucleic Acid Sensors (1557 citations)
- A Colorimetric Lead Biosensor Using DNAzyme-Directed Assembly of Gold Nanoparticles (1096 citations)
- Fast Colorimetric Sensing of Adenosine and Cocaine Based on a General Sensor Design Involving Aptamers and Nanoparticles (825 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Nanotechnology, Deoxyribozyme, Biochemistry, DNA and Stereochemistry.
In his work, Analyte is strongly intertwined with Aptamer, which is a subfield of Nanotechnology.
As a part of the same scientific study, Yi Lu usually deals with the Deoxyribozyme, concentrating on Combinatorial chemistry and frequently concerns with Catalysis.
His studies deal with areas such as RNA and Molecule as well as DNA.
His work carried out in the field of Stereochemistry brings together such families of science as Myoglobin and Heme.
As part of the same scientific family, he usually focuses on Heme, concentrating on Photochemistry and intersecting with Copper.
He most often published in these fields:
- Nanotechnology (24.11%)
- Deoxyribozyme (15.24%)
- Biochemistry (12.75%)
What were the highlights of his more recent work (between 2017-2021)?
- Deoxyribozyme (15.24%)
- Combinatorial chemistry (9.33%)
- DNA (11.51%)
In recent papers he was focusing on the following fields of study:
His main research concerns Deoxyribozyme, Combinatorial chemistry, DNA, Nanotechnology and Catalysis.
His work deals with themes such as Cleavage, Metal ions in aqueous solution and Biosensor, which intersect with Deoxyribozyme.
His Combinatorial chemistry research incorporates themes from Amino acid, Heme, Enzyme and Nucleation.
His DNA research is multidisciplinary, incorporating perspectives in Nanoparticle, Biophysics, microRNA and Aptamer.
His studies examine the connections between Aptamer and genetics, as well as such issues in Drug delivery, with regards to Cancer cell.
His Nanotechnology research includes themes of Oligonucleotide and Nir light.
Between 2017 and 2021, his most popular works were:
- Upconversion Luminescence-Activated DNA Nanodevice for ATP Sensing in Living Cells (87 citations)
- Optical Control of Metal Ion Probes in Cells and Zebrafish Using Highly Selective DNAzymes Conjugated to Upconversion Nanoparticles (58 citations)
- Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets. (56 citations)
In his most recent research, the most cited papers focused on:
Yi Lu spends much of his time researching Nanotechnology, DNA, Deoxyribozyme, Combinatorial chemistry and Aptamer.
His Nanotechnology research includes elements of Oligonucleotide and Nir light.
His DNA study frequently draws connections to other fields, such as Nanoparticle.
His biological study spans a wide range of topics, including Biophysics, Selection method, Metal ions in aqueous solution and Biosensor.
His Combinatorial chemistry research is multidisciplinary, incorporating elements of Amino acid, Boron, Enzyme, Phosphodiester bond and Catalysis.
His study in Aptamer is interdisciplinary in nature, drawing from both Mitochondrion, Nucleic acid and Drug delivery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
